Podcast

  • EPISODE 12- Winning the Drug Development Relay Race
    02.11.2022

    In this episode, we interview Johannes Fruehauf on how drug development is similar to a relay race, and investment into a drug development ecosystem.

  • EPISODE 11- New Modalities: The Future of Drug Development
    12.21.2021

    In this episode, we interview Jean-Francois Formela, Partner at Atlas Venture, about what brought him to Washington and his views on the government’s role in drug development.

  • EPISODE 10- The Investor’s Paradox, Drug Development, & Price Controls
    11.02.2021

    This episode features Peter Kolchinsky, Managing Partner at RA Capital Management, on the state of drug development and the investor's paradox.

  • EPISODE 9- MIT Takeover: A MedTech-VC Partnership Working to Reduce Parkinson’s Tremors
    10.19.2021

    This episode is an MIT takeover, hosted by guest Lindsay Androski Founder, President, and CEO at Roivant Social Ventures and President, Board Member at Incubate Coalition, who discuss wearable solutions for Parkinson's Disease tremors.

  • EPISODE 8- Venture Capital Investors: The Underwriters of Innovation
    09.28.2021

    In this episode, we interview three guests about a collaboration story that represents the best of a healthy healthcare ecosystem.

  • EPISODE 7- The Hidden Cost of Price Control Policies
    09.21.2021

    In this episode, we interview Kirsten Axelsen, Senior Advisor at Charles Rivers Associates, about what would change in biopharma if price controls were implemented.

  • EPISODE 6- You Cannot Make Medicine Alone: Relationships & Mentoring
    07.27.2021

    In this episode, we interview Imran Nasrullah, Vice President & Head, Open Innovation Center North America - East at Bayer Pharmaceuticals, about strengthening relationships within the biotech ecosystem.

  • EPISODE 5- Improving the Standard of Care with Patients in Mind
    07.13.2021

    In this episode, we interview Gaurav Gupta and Hugo Beekman, Co-Founders of Ascendant BioCapital, to discuss their organization and how they’re focusing on drugs that truly make a difference for patients.

  • EPISODE 4- The Truth About Pharmaceuticals
    06.29.2021

    In this episode, we interview Ravi Mehrotra, Thought Leader and former Senior Managing Director of Biotechnology Equity Research at Evercore ISI on the drug pricing debate, misconceptions about the pharmaceutical industry, and HR 3

  • EPISODE 3- Valuing Inventors & Entrepreneurs: Changing the Dialogue of IP
    06.15.2021

    In this episode, we interview Andrei Iancu, Former Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, to discuss his views and concerns on IP rights.

  • EPISODE 2- AMR: Challenges and Insight
    05.31.2021

    In this episode, we interview Alfonso Chang, the Managing Director of Relativity Healthcare Partners. He discusses the fight against Antimicrobial Resistance (AMR) and how to overcome challenges in finding cures.

  • EPISODE 1- 40 Years in Review: Bayh-Dole to 2021
    05.15.2021

    In this episode, we interview Joseph Allen, from Joseph Allen and Associates, to discuss the Bayh-Dole Act and how it still impacts IP 40 years later.